Evaluation of the Immunogenicity and Safety of Concomitant Administration of Novel Oral Polio Type 2 Vaccine and Bivalent Oral Polio Vaccine

Condition:   Poliomyelitis Intervention:   Biological: bOPV and nOPV2 Sponsors:   Fidec Corporation;   Bill and Melinda Gates Foundation Withdrawn
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials